Psychiatry and Neurology, Neurology · West Palm Beach, FL
NPI
1801004841
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4631 North Congress Ave, Suite 200
West Palm Beach, FL, 33407
Phone (561) 845-0500
Groups this clinician bills Medicare through
Medicare paid, 2024
$477K
71,793 services
Medicare patients, 2024
274
Average age 72
Drug cost, 2024
$1.0M
2,031 prescriptions
Company payments, 2025
$18K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arnaldo N Da Silva was code J0585 (injection, onabotulinumtoxina, 1 unit), 70,900 times for 126 patients. In total Arnaldo N Da Silva billed 71,793 services in 15 codes, and Medicare paid $477K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 70,900 | 126 | $4.94 | $350K |
| 64615 Musculoskeletal | Office | 351 | 125 | $122.05 | $43K |
| 99214 Office E&M - Established | Office | 303 | 163 | $96.95 | $29K |
| 95819 Neurologic | Office | 112 | 112 | $337.67 | $38K |
| 99205 Office E&M - New | Office | 65 | 65 | $173.03 | $11K |
| 99204 Office E&M - New | Office | 20 | 20 | $134.61 | $2,692 |
By year: 2022 $420K for 62,063 services; 2023 $432K for 63,849 services; 2024 $477K for 71,793 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arnaldo N Da Silva prescribed most often to Medicare patients was Qulipta (Atogepant), with 207 prescriptions and refills. In total Arnaldo N Da Silva wrote 2,031 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Qulipta Atogepant | 207 | 230 | 42 | $240K |
| Emgality Pen Galcanezumab-Gnlm | 191 | 229 | 39 | $155K |
| Ajovy Autoinjector Fremanezumab-Vfrm | 160 | 193 | 26 | $139K |
| Botox Onabotulinumtoxina | 111 | 311 | 38 | $152K |
| Gabapentin Generic | 108 | 151 | 37 | $1,274 |
| Sumatriptan Succinate Generic | 101 | 124 | 25 | $3,034 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 87 | 87 | 22 | $1,428 |
| Naratriptan Hcl Generic | 81 | 97 | 19 | $6,578 |
| Nurtec Odt Rimegepant Sulfate | 77 | 78 | 25 | $134K |
| Aimovig Autoinjector Erenumab-Aooe | 73 | 81 | 13 | $59K |
| Topiramate Generic | 65 | 119 | 19 | $534 |
| Rizatriptan Rizatriptan Benzoate | 61 | 92 | 15 | $1,569 |
| Ubrelvy Ubrogepant | 58 | 60 | 19 | $80K |
| Ondansetron Odt Ondansetron | 45 | 49 | 14 | $863 |
| Pregabalin Generic | 42 | 54 | 16 | $1,462 |
Brand drugs: 936 claims; generic drugs: 1,095 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arnaldo N Da Silva $18K ($18K in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbvie Inc. with $8,273.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.